“We need to think about how we’re going to provide care for patients who may be recovering for years after the virus,” said one pulmonologist and director of University of Colorado’s post-COVID clinic.
Did you know that establishing clear and measurable treatment goals can improve pain-related outcomes? Listen to our expert Dr Jeff Gudin to learn more.
Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop treatment, yet many oncologists are unaware of…
A comprehensive summary covering international recommendations on preventing and managing osteoporosis and fractures
This interactive session will dive into how LAIs can significantly improve treatment adherence, provide greater stability, and enhance quality of life for in…
The evidence suggests “yes,” “no,” and “maybe,” depending on who you ask. But most experts agree that better research is needed.
The incidence of MASH is on the rise. Learn more about determining risk in your patients and the new and emerging therapies available.
Adoption of active surveillance or watchful waiting has been increasing among patients with intermediate-risk prostate cancer between 2010 and 2020, a new analysis found.
Were you aware of the FDA’s Purple Book, an online database that contains information about biosimilar and interchangeable biological products approved by the FDA?
Dr Roger Henderson summarises the diagnosis, investigation, management, and referral of diverticular disease and acute diverticulitis in general practice
Childhood exposure to leaded gasoline over the past 75 years has been linked to 151 million excess cases of psychiatric disorders, a new population-based study…
